C

Carelabs Co Ltd
KOSDAQ:263700

Watchlist Manager
Carelabs Co Ltd
KOSDAQ:263700
Watchlist
Price: 2 645 KRW -3.82% Market Closed
Market Cap: ₩51.3B

Carelabs Co Ltd
Cash & Cash Equivalents

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Carelabs Co Ltd
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
C
Carelabs Co Ltd
KOSDAQ:263700
Cash & Cash Equivalents
₩42.3B
CAGR 3-Years
18%
CAGR 5-Years
5%
CAGR 10-Years
N/A
I
Infinitt Healthcare Co Ltd
KOSDAQ:071200
Cash & Cash Equivalents
₩14.7B
CAGR 3-Years
N/A
CAGR 5-Years
1%
CAGR 10-Years
-3%
U
UBCare Co Ltd
KOSDAQ:032620
Cash & Cash Equivalents
₩10.2B
CAGR 3-Years
-29%
CAGR 5-Years
-24%
CAGR 10-Years
1%
L
LifeSemantics Corp
KOSDAQ:347700
Cash & Cash Equivalents
₩19.3B
CAGR 3-Years
-7%
CAGR 5-Years
63%
CAGR 10-Years
N/A
L
Lunit Inc
KOSDAQ:328130
Cash & Cash Equivalents
₩1B
CAGR 3-Years
-59%
CAGR 5-Years
-51%
CAGR 10-Years
N/A
J
JLK Inc
KOSDAQ:322510
Cash & Cash Equivalents
₩9.1B
CAGR 3-Years
22%
CAGR 5-Years
10%
CAGR 10-Years
N/A
No Stocks Found

Carelabs Co Ltd
Glance View

Market Cap
51.3B KRW
Industry
Health Care

Carelabs Co., Ltd. is a healthcare platform company that provides optimal software and content services. The company is headquartered in Seoul, Seoul. The company went IPO on 2018-03-28. Along with subsidiaries, the Company operates its business through three segments. The Healthcare Digital Marketing segment is involved in marketing planning, production and agency business. The Healthcare Media Platform segment is involved in the provision of hospital pharmacy search services and community apps related to beauty care. The products are sold under the name of GOODOC and BABITALK. The Healthcare Solution segment provides customer relationship management (CRM) software, prescription security systems, and pharmacy billing programs. The firm distributes its products within the domestic market and to overseas markets.

Intrinsic Value
5 021.39 KRW
Undervaluation 47%
Intrinsic Value
Price ₩2 645
C

See Also

What is Carelabs Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
42.3B KRW

Based on the financial report for Sep 30, 2025, Carelabs Co Ltd's Cash & Cash Equivalents amounts to 42.3B KRW.

What is Carelabs Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
5%

Over the last year, the Cash & Cash Equivalents growth was 31%. The average annual Cash & Cash Equivalents growth rates for Carelabs Co Ltd have been 18% over the past three years , 5% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett